This company is no longer active
이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Tricida 관리
관리 기준 확인 3/4
Tricida's CEO is Gerrit Klaerner, appointed in Aug 2013, they has a tenure of 9.83 years. Their total yearly compensation is $4.68M , comprised of 12.8% salary and 87.2% bonuses, including company stock and options. They directly owns 0.68% of the company’s shares, worth $3.93. The average tenure of the management team and the board of directors is 4 years and 9.5 years respectively.
주요 정보
Gerrit Klaerner
최고 경영자
US$4.7m
총 보상
CEO 급여 비율 | 12.8% |
CEO 임기 | 9.8yrs |
CEO 소유권 | 0.7% |
경영진 평균 재임 기간 | 4yrs |
이사회 평균 재임 기간 | 9.5yrs |
최근 관리 업데이트
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29CEO 보상 분석
날짜 | 총 보상 | 급여 | 회사 수익 |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$134m |
Jun 30 2022 | n/a | n/a | -US$148m |
Mar 31 2022 | n/a | n/a | -US$153m |
Dec 31 2021 | US$5m | US$600k | -US$177m |
Sep 30 2021 | n/a | n/a | -US$181m |
Jun 30 2021 | n/a | n/a | -US$219m |
Mar 31 2021 | n/a | n/a | -US$244m |
Dec 31 2020 | US$9m | US$598k | -US$265m |
Sep 30 2020 | n/a | n/a | -US$268m |
Jun 30 2020 | n/a | n/a | -US$235m |
Mar 31 2020 | n/a | n/a | -US$213m |
Dec 31 2019 | US$10m | US$584k | -US$177m |
Sep 30 2019 | n/a | n/a | -US$146m |
Jun 30 2019 | n/a | n/a | -US$131m |
Mar 31 2019 | n/a | n/a | -US$120m |
Dec 31 2018 | US$1m | US$503k | -US$103m |
Sep 30 2018 | n/a | n/a | -US$96m |
Jun 30 2018 | n/a | n/a | -US$77m |
Mar 31 2018 | n/a | n/a | -US$60m |
Dec 31 2017 | US$821k | US$425k | -US$41m |
보상 대 시장: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the US market ($USD747.42K).
보상과 수익: Gerrit's compensation has been consistent with company performance over the past year.
CEO
Gerrit Klaerner (51 yo)
9.8yrs
테뉴어
US$4,676,490
보상
Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...
리더십 팀
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Founder | 9.8yrs | US$4.68m | 0.68% $ 3.9 | |
COO, CFO & Executive VP | 6.2yrs | US$2.51m | 0.72% $ 4.2 | |
Executive VP | 3.3yrs | US$2.43m | 0.031% $ 0.2 | |
Executive Vice President of Clinical Development | 4.8yrs | US$2.77m | 0.0060% $ 0.03 | |
VP of Finance & Chief Accounting Officer | 2.5yrs | 데이터 없음 | 데이터 없음 | |
Vice President of Investor Relations & Communications | no data | 데이터 없음 | 데이터 없음 | |
Executive Vice President of Intellectual Property | 3.3yrs | US$2.10m | 데이터 없음 |
4.0yrs
평균 재임 기간
58yo
평균 연령
경험이 풍부한 관리: TCDA.Q's management team is considered experienced (4 years average tenure).
이사회 구성원
이름 | 위치 | 테뉴어 | 보상 | 소유권 |
---|---|---|---|---|
Founder | 9.9yrs | US$4.68m | 0.68% $ 3.9 | |
Independent Non-Employee Director | 5.1yrs | US$329.00k | 0.074% $ 0.4 | |
Independent Chairman of the Board | 9.3yrs | US$379.00k | 0.20% $ 1.1 | |
Independent Non-Employee Director | 6.9yrs | US$326.50k | 0.019% $ 0.1 | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.7yrs | US$314.00k | 데이터 없음 | |
Member of Scientific & Clinical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Member of Scientific & Clinical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Member of Scientific & Clinical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.9yrs | US$316.50k | 0.15% $ 0.9 | |
Member of Scientific & Clinical Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
Member of Scientific & Clinical Advisory Board | no data | 데 이터 없음 | 데이터 없음 | |
Member of Scientific and Clinical Advisory Board | no data | 데이터 없음 | 데이터 없음 |
9.5yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 이사회: TCDA.Q's board of directors are considered experienced (9.5 years average tenure).